News & Insights

Venebio to Demo Opioid Overdose Risk-Screening Tool, Venebio Opioid Advisor, at Health 2.0

Demo to be part of breakout session, “Platforms for Provider Decision Support,” on Monday, October 2, at 11:30 a.m. in Grand Ballroom D Venebio Group, a leader in personalized risk prediction algorithms, will be demoing its risk-screening tool for prescription opioid overdose, Venebio Opioid Advisor™ (VOA™), at the 11th annual Health 2.0 conference in Santa […]

5 differences between a systematic review and other types of literature review

There are many types of reviews of the medical and public health evidence, each with its own benefits and challenges. In this blog post, we detail five key differences between a systematic review and other types of reviews, including narrative and comprehensive reviews. First, we must define some terms. “Literature review” is a general term […]

Second Health Plan to Implement Venebio’s Opioid Overdose Risk-Screening Tool

Recently published white paper estimates tool could result in 15% fewer prescription opioid overdoses RICHMOND, Va. (September 22, 2017) – Venebio Group, a leader in personalized risk prediction algorithms, today announced that Amida Care, a New York-based health plan provider, has implemented Venebio Opioid Advisor™ (VOA™), the company’s risk-screening tool for prescription opioid overdose. Amida […]

Substance Use Disorder Terminology Clarified

Diagnostic terminology in the field of substance use disorders (SUD) has become complicated, nuanced and open to interpretation by researchers and practitioners in different fields. Its tortured history is reflected in confusion among experts and non-experts alike. The glossary below may help clarify some common SUD-related definitions to provide some guidance as we continue conversations […]

Five questions to ask before you choose a target journal for publication

When you’ve spent, weeks, months – even years – working on a publication, you want to make sure you find the perfect journal to review and publish your findings. Targeting an inappropriate journal can result in extreme delays in time to publication or reaching an unsuitable or too small reading audience, among other things. Don’t […]

Predictive Analytics in the Public Health Arena

Millions of series of zeros and ones are behind everything we do as scientific research and healthcare professionals. We’re able to process this data through dozens of different lenses, but what gets us truly excited is the growing ability to use predictive analytics to improve population health. Venebio’s focus in predictive analytics has typically aligned […]

Venebio presents at ISPOR 2017

Recent legislative changes such as the Patient Protection and Affordable Care Act, HITECH, and the Medicare Access and CHIP Reauthorization Act are forcing the health care industry to find ways to improve quality and outcomes while lowering costs. Information technology and predictive analytics are being explored to identify viable, “cost-neutral” solutions to help achieve those […]

Recipe for the perfect meta-analysis

So, you’ve conducted a systematic review of the evidence on your topic, and you’re not sure whether you can—or should—combine the data quantitatively. It’s a common question, and there’s no “right” answer. However, the following considerations can help guide you toward the best decision. How many studies? One of the most frequently asked questions in […]

Venebio Launches Tool to Help Reduce Opioid Overdoses: Initial adopters of Venebio Opioid Advisor include health plans and Medicaid-managed care plans in Virginia and New York

RICHMOND, Va. (July 12, 2017) – Venebio Group, a leader in personalized risk prediction algorithms, today announced that its risk-screening tool for opioid overdose, Venebio Opioid Advisor™ (VOA™), is now commercially available nationwide following the conclusion of its pilot phase. While much of the national attention around the opioid epidemic has focused on addiction, many […]

Study of U.S. Opioid Users Shows Venebio’s Overdose Risk Index to Have 90% Accuracy

Richmond, Va. – April 13, 2017 – A recent study published in Pain Medicine validates the strong performance of Venebio Group’s risk index tool — Venebio Opioid Advisor (VOA) — at predicting the likelihood of a life-threatening overdose in patients taking a prescription opioid. Prescription opioid sales quadrupled in the United States between 1999 and […]